Comparison of Venlafaxine and Bupropion on depression of Bipolar II disorder
Phase 2
Recruiting
- Conditions
- Bipolar II disorder.Bipolar II disorderF31.81
- Registration Number
- IRCT20200913048698N1
- Lead Sponsor
- Ahvaz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Diagnosis of Depressive episode of Bipolar II disorder according to DSM V
Ability to take oral medication
informed consent from the patient or parents
The patient has not used another antidepressant within four weeks of starting the drug
Exclusion Criteria
Sucidal tought
Psychosis
The current episode is mixed
Rapid cycling
Dyspepsia or peptic ulcer
Pregnant and lactating women
Intellectual disabilitie
History of alcohol and substance abuse up to six months before the start of the project
The patient's depression is caused by a physical illness using drugs or medication
Existence of any severe and chronic physical illness, cerebrovascular disease, seizures or history of substance use
Psychotic depression
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Depression Score Hamilton Questionnaire. Timepoint: Depression score of Hamilton questionnaire is calculated before intervention, and 14, 21 and 28 days after intervention. Method of measurement: Hamilton Questionnaire.
- Secondary Outcome Measures
Name Time Method Hypo mania score with MDQ questionnaire. Timepoint: Before starting the intervention. Method of measurement: MDQ Questionnaire.